1. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event
- Author
-
Arman Qamar, Martin Magnusson, Jacob E. Møller, Peter M. Nilsson, Tor Biering-Sørensen, Axel Cosmus Pyndt Diederichsen, Deepak L. Bhatt, Michael H. Olsen, Manan Pareek, Margret Leosdottir, Peter Hindersson, and Muthiah Vaduganathan
- Subjects
Blood Glucose ,Male ,Pathology ,Epidemiology ,030204 cardiovascular system & hematology ,Kidney ,0302 clinical medicine ,Interquartile range ,Risk Factors ,Natriuretic Peptide, Brain ,Clinical endpoint ,030212 general & internal medicine ,Myocardial infarction ,Prospective Studies ,education.field_of_study ,biology ,Incidence ,Middle Aged ,Brain natriuretic peptide ,Prognosis ,Echocardiography, Doppler ,Cardiovascular Diseases ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,Procollagen ,Cohort study ,medicine.medical_specialty ,Growth Differentiation Factor 15 ,Population ,03 medical and health sciences ,Troponin T ,Predictive Value of Tests ,Internal medicine ,medicine ,Journal Article ,Humans ,education ,Aged ,Proportional Hazards Models ,Sweden ,Chi-Square Distribution ,business.industry ,Interleukin-6 ,medicine.disease ,Peptide Fragments ,Logistic Models ,Cystatin C ,Heart failure ,Multivariate Analysis ,biology.protein ,Linear Models ,business ,Biomarkers - Abstract
Aims To assess the incremental value of biomarkers, including N-terminal prohormone of brain natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hs-TnT), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), growth differentiation factor 15 (GDF-15), and procollagen type 1 N-terminal propeptide (P1NP), in predicting incident cardiovascular events and mortality among asymptomatic individuals from the general population, beyond traditional risk factors, including fasting glucose and renal function (cystatin C), medication use, and echocardiographic measures. Methods and results Prospective population-based cohort study of 1324 subjects without a previous cardiovascular event, who underwent baseline echocardiography and biomarker assessment between 2002 and 2006. The clinical endpoint was the composite of myocardial infarction, invasively treated stable/unstable ischemic heart disease, heart failure, stroke, or all-cause mortality. Predictive capabilities were evaluated using Cox proportional-hazards regression, Harrell's concordance index (C-index), and net reclassification improvement. Median age was 66 (interquartile range: 60-70) years, and 413 (31%) were female. During median 8.6 (interquartile range: 8.1-9.2) follow-up years, 368 (28%) composite events occurred. NT-proBNP, hs-TnT, GDF-15, and IL-6 were significantly associated with outcome, independently of traditional risk factors, medications, and echocardiography ( p
- Published
- 2017
- Full Text
- View/download PDF